Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 June, 2018 10:01 IST
Sun Pharma announces USFDA approval of YONSA
Source: IRIS | 23 May, 2018, 09.51AM
Comments  |  Post Comment

Sun Pharmaceutical Industries and Churchill Pharmaceuticals, LLC. (Churchill) announced that one of Sun Pharma’s wholly owned subsidiary companies has received approval from the U.S. Food and Drug Administration (FDA) for YONSA (abiraterone acetate), a novel formulation in combination with methylprednisolone, for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).

Churchill is eligible to receive upfront and sales-linked milestone payments, and royalties on sales from Sun Pharma (Q,N,C,F)* pursuant to an agreement between the two companies to commercialize YONSA in the U.S.

''We are pleased to add YONSA to our growing oncology portfolio and continue to deliver on Sun Pharma's commitment for enhanced patient access to innovative cancer therapies,'' said Abhay Gandhi, CEO-North America, Sun Pharma.

YONSA in combination with methylprednisolone was filed as a New Drug Application (NDA) under the 505(b)(2) regulatory pathway and will be promoted as a branded product in the U.S.

Shares of the company gained Rs 5.15, or 1.14%, to trade at Rs 458.15. The total volume of shares traded was 54,333 at the BSE (9.36 a.m., Wednesday).



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Cords Cable wins bulk order worth Rs 472 mn - 19-Jun-2018 09:59
Glenmark Pharma gets sANDA approval for facility in Monroe, North California - 19-Jun-2018 09:55
Strides Shasun receives USFDA approval for Ketoconazole Tablets - 19-Jun-2018 09:50
Dr. Reddy's defends right to launch Buprenorphine and Naloxone Sublingual Film - 18-Jun-2018 12:40
Lupin, Nichi-Iko in pact for commercialisation of Etanercept in Japan - 18-Jun-2018 11:38
Yes Bank gets SEBI approval for offering custodial services - 18-Jun-2018 10:06
Fitch affirms at Axis Bank and ICICI Bank's issuer rating at BBB- - 15-Jun-2018 15:36
Fitch affirms at Axis Bank and ICICI Bank's issuer rating at BBB- - 15-Jun-2018 15:36
Dhunseri Petrochem to exit JV in Egypt with Indorama - 15-Jun-2018 15:22
NBCC bags orders worth Rs 4.80 bn in May 2018 - 15-Jun-2018 15:16
Jammu and Kashmir Bank to raise tier-I capital up to Rs 10 bn - 15-Jun-2018 11:26
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer